Blood biomarkers for monitoring and prognosis of large vessel vasculitides

E Tombetti, E Hysa, JC Mason, MA Cimmino… - Current Rheumatology …, 2021 - Springer
Abstract Purpose of Review Large vessel vasculitides (LVVs) are inflammatory conditions of
the wall of large-sized arteries, mainly represented by giant cell arteritis (GCA) and …

[HTML][HTML] Outcome measures and biomarkers for disease assessment in Takayasu arteritis

DP Misra, N Jain, M Ora, K Singh, V Agarwal… - Diagnostics, 2022 - mdpi.com
Takayasu arteritis (TAK) is a less common large vessel vasculitis where histopathology of
involved arteries is difficult to access except during open surgical procedures. Assessment …

Advances in Takayasu arteritis: an Asia Pacific perspective

D Danda, P Manikuppam, X Tian, M Harigai - Frontiers in Medicine, 2022 - frontiersin.org
Takayasu Arteritis (TA) is a rare form of chronic granulomatous large vessel vasculitis that is
more common in Asia compared to other parts of the world. There have been several …

Current diagnosis and management of Takayasu arteritis

D Danda - International Heart Journal, 2023 - jstage.jst.go.jp
Takayasu arteritis (TA or TAK) is a chronic large vessel vasculitis with predilection to affect
the aorta and its branches. The new 2022 ACR/EULAR classification criteria for Takayasu …

Common autoantibody among takayasu arteritis and ulcerative colitis: A possible pathophysiology that includes gut-vessel connection in vascular inflammation

T Shirai - JMA journal, 2023 - jstage.jst.go.jp
Takayasu arteritis (TAK) is a type of large-vessel vasculitis that predominantly affects young
females. The precise pathomechanism of TAK is still under investigation. In TAK, the vasa …

Exploration of molecular signatures associated with different clinical features of Takayasu arteritis based on a prospective cohort study

X Kong, J Wang, R Chen, Y Sun, H Chen, L Ma… - Clinical …, 2023 - Elsevier
Takayasu arteritis (TAK) is complicated disorder without reliable biomarkers. Here, we
aimed to explore TAK-associated factor panels and their changes after biologic treatment …

A Glimpse into Humoral Response and Related Therapeutic Approaches of Takayasu's Arteritis

S Guo, Y Tian, J Li, X Zeng - International Journal of Molecular Sciences, 2024 - mdpi.com
Takayasu's arteritis (TAK) manifests as an insidiously progressive and debilitating form of
granulomatous inflammation including the aorta and its major branches. The precise …

Elevated serum immunoglobulin level predicts high risk of 1-year recurrence in patients with Takayasu arteritis

Y Guo, J Du, T Li, N Gao, S Yang, Y Zhang… - Arthritis Research & …, 2023 - Springer
Background The mechanism of humoral immunity to Takayasu arteritis (TAK) is not clear. In
our study, we aimed to investigate the correlation between immunoglobulins and disease …

Serum Biomarker Profile Explains Heterogenity in Patients With Takayasu Arteritis: An Exploratory Analysis

R Goel, D Anantharaman, SB Prabhu, R Raghupathy… - 2023 - researchsquare.com
The clinical presentation of patients with Takayasu arteritis (TAK), a large vessel vasculitis, is
heterogenous and absence on an ideal biomarker renders assessment of disease activity …

[HTML][HTML] Takayasu arteritinde aktivite değerlendirmesi ve prognoz

SK Tahra, FA Öner - 2022 - raeddergisi.org
Takayasu arteriti (TAK) izleminde hastalık aktivite değerlendirilmesi kritik öneme sahiptir.
Ancak şimdiye kadar geliştirilmiş ölçekler TAK'de hastalık aktivitesini değerlendirmede …